Your browser doesn't support javascript.
loading
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.
Pinquie, François; Cortot, Alexis B; Chevalier, Louise-Marie; Morel, Alain; Sandrini, Jérémy; Guguen, Camille; Morvan, Benjamin; Molinier, Olivier.
Afiliação
  • Pinquie F; Department of Respiratory Diseases, Le Mans Hospital Center, 72000 Le Mans, France.
  • Cortot AB; Department of Thoracic Oncology, Lille University Hospital, CNRS, Inserm, Institut Pasteur de Lille, Canther, F-59000, Lille, France.
  • Chevalier LM; Angers University, Inserm, 49000 Angers, France; Department of Oncogenomic, Cancer Center Paul Papin, 49000 Angers, France.
  • Morel A; Angers University, Inserm, 49000 Angers, France; Department of Oncogenomic, Cancer Center Paul Papin, 49000 Angers, France.
  • Sandrini J; Department of Pathology, Le Mans Hospital Center, 72000 Le Mans, France.
  • Guguen C; Department of Respiratory Diseases, Le Mans Hospital Center, 72000 Le Mans, France.
  • Morvan B; Department of Pathology, Le Mans Hospital Center, 72000 Le Mans, France.
  • Molinier O; Department of Respiratory Diseases, Le Mans Hospital Center, 72000 Le Mans, France. Electronic address: omolinier@ch-lemans.fr.
Clin Lung Cancer ; 23(2): e131-e134, 2022 03.
Article em En | MEDLINE | ID: mdl-34548228

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Crizotinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Crizotinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article